Status:
UNKNOWN
Indwelling vs Intermittent Catheterization Pilot Study
Lead Sponsor:
Ottawa Hospital Research Institute
Collaborating Sponsors:
The Ottawa Hospital
Conditions:
Urogenital
Urinary Tract Infections
Eligibility:
All Genders
50+ years
Phase:
NA
Brief Summary
The primary aim of the proposed pilot feasibility is to determine whether it is feasible to recruit patients with a hip fracture into a prospective study and randomize them to either indwelling or int...
Detailed Description
The primary aim of the proposed pilot feasibility is to determine whether it is feasible to recruit patients with a hip fracture into a prospective study and randomize them to either indwelling or int...
Eligibility Criteria
Inclusion
- Hip fracture (intertrochanteric, femoral neck, femoral head, sub-trochanteric) confirmed by imaging
- Age ≥50 years
- Operative treatment planned
- Admitted under Orthopaedic Surgery
- Willing and able to sign consent (substitute decision maker)
Exclusion
- Periprosthetic hip fracture
- Polytrauma
- Multiple fractures of the lower limbs
- Previous lower urinary tract surgery
- Known (past or current) urogenital cancer (prostate, bladder)
- Urinary tract infection prior to randomization
- Indwelling catheter present on admission (chronic or placed at previous acute setting)
Key Trial Info
Start Date :
June 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2023
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT05354921
Start Date
June 1 2022
End Date
July 1 2023
Last Update
May 2 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Ottawa Hospital
Ottawa, Ontario, Canada, K1H 8L6